Psoriasis Terminated Phase Trials for Etanercept (DB00005)

Also known as: Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00477191Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and PsoriasisPrevention